Mutational profiling allows the stratification of metastatic colorectal cancer patients with poor prognosis

被引:0
|
作者
Rodriguez Hernandez, A. [1 ]
LaHoz, S. [2 ]
Laia, F. M. [3 ]
Gorria Puga, T. [3 ]
Moreno, R. [3 ]
Esposito, F. [4 ]
Oliveres, H. [1 ]
Albiol Rodriguez, S. [3 ]
Sauri, T. [3 ]
Cuatrecasas, M. [3 ]
Jares, P. [3 ]
Pedrosa, L. [2 ]
Pineda, E. [3 ]
Castells, A. [3 ]
Prat, A. [3 ]
Camps, J. [2 ]
Maurel, J. [3 ]
机构
[1] Hosp Clin Barcelona, Dept Oncol, Barcelona, Spain
[2] IDIBAPS, Biostat, Barcelona, Spain
[3] Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain
[4] Hosp Clin Barcelona, Med Oncol, Barcelona, Spain
关键词
D O I
10.1016/j.annonc.2020.08.587
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
476P
引用
收藏
页码:S443 / S443
页数:1
相关论文
共 50 条
  • [41] Mutational profiling using liquid biopsy to guide targeted therapy in patients with metastatic cancer
    Omayma Mazouji
    Abdelhak Ouhajjou
    Naima Anouar
    Chakib Nejjari
    Roberto Incitti
    Hicham Mansour
    Scientific Reports, 15 (1)
  • [42] Podocalyxin is a marker of poor prognosis in colorectal cancer
    Kaprio, Tuomas
    Fermer, Christian
    Hagstroem, Jaana
    Mustonen, Harri
    Boeckelman, Camilla
    Nilsson, Olle
    Haglund, Caj
    BMC CANCER, 2014, 14
  • [43] Podocalyxin is a marker of poor prognosis in colorectal cancer
    Tuomas Kaprio
    Christian Fermér
    Jaana Hagström
    Harri Mustonen
    Camilla Böckelman
    Olle Nilsson
    Caj Haglund
    BMC Cancer, 14
  • [44] Association of mesenchymal phenotype in circulating tumor cells with poor prognosis in metastatic colorectal cancer.
    Dasari, Arvind
    Gao, Hui
    Deaton, Laurel
    Overman, Michael J.
    Hauch, Siegfried
    Kopetz, Scott
    Reuben, James M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [45] High preoperative serum ferritin predicted poor prognosis in non-metastatic colorectal cancer
    Hong Tingting
    Shen Di
    Chen Xiaoping
    Wu Xiaohong
    Hua Dong
    SAUDI MEDICAL JOURNAL, 2017, 38 (03) : 268 - 275
  • [46] Mutational status and metastatic patteRn in a cohort Of ADvanced colorectal cancer patients: the ROAD study
    Ongaro, E.
    De Maglio, G.
    Gerratana, L.
    Bonotto, M.
    Garattini, S. K.
    Basile, D.
    Cattaneo, M.
    Andreotti, V. J.
    Cortiula, F.
    Parnofiello, A.
    Fanotto, V.
    Pizzolitto, S.
    Cardellino, G. G.
    Casagrande, M.
    Ermacora, P.
    Giovannoni, M.
    Iacono, D.
    Puglisi, F.
    Aprile, G.
    Pella, N.
    Fasola, G.
    ANNALS OF ONCOLOGY, 2017, 28
  • [47] Mutational status of plasma exosomal KRAS predicts outcome in patients with metastatic colorectal cancer
    Donatella Lucchetti
    Ina Valeria Zurlo
    Filomena Colella
    Claudio Ricciardi-Tenore
    Mariantonietta Di Salvatore
    Giampaolo Tortora
    Ruggero De Maria
    Felice Giuliante
    Alessandra Cassano
    Michele Basso
    Antonio Crucitti
    Ilaria Laurenzana
    Giulia Artemi
    Alessandro Sgambato
    Scientific Reports, 11
  • [48] Mutational status of plasma exosomal KRAS predicts outcome in patients with metastatic colorectal cancer
    Lucchetti, Donatella
    Zurlo, Ina Valeria
    Colella, Filomena
    Ricciardi-Tenore, Claudio
    Di Salvatore, Mariantonietta
    Tortora, Giampaolo
    De Maria, Ruggero
    Giuliante, Felice
    Cassano, Alessandra
    Basso, Michele
    Crucitti, Antonio
    Laurenzana, Ilaria
    Artemi, Giulia
    Sgambato, Alessandro
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [49] Mutational Screening of the SOCS3 Gene Promoter in Metastatic Colorectal Cancer Patients
    Igci, Mehri
    Cakmak, Ecir Ali
    Oztuzcu, Serdar
    Bayram, Ali
    Arslan, Ahmet
    Gogebakan, Bulent
    Igci, Yusuf Ziya
    Cengiz, Beyhan
    Ozkara, Esma
    Camci, Celaletdin
    Demiryurek, A. Tuncay
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2012, 16 (12) : 1395 - 1400
  • [50] COLORECTAL-CANCER - METASTATIC PATTERNS AND PROGNOSIS
    PATANAPHAN, V
    SALAZAR, OM
    SOUTHERN MEDICAL JOURNAL, 1993, 86 (01) : 38 - 41